Cantor Fitzgerald Comments on MREO FY2026 Earnings
Mereo BioPharma Group plc (NASDAQ:MREO – Free Report) – Equities research analysts at Cantor Fitzgerald issued their FY2026 EPS estimates for Mereo BioPharma Group in a research note issued on Monday, June 9th. Cantor Fitzgerald analyst K. Kluska anticipates that the company will post earnings of ($0.08) per share for the year. Cantor Fitzgerald has […]
Mereo BioPharma Group plc (NASDAQ:MREO – Free Report) – Equities research analysts at Cantor Fitzgerald issued their FY2026 EPS estimates for Mereo BioPharma Group in a research note issued on Monday, June 9th. Cantor Fitzgerald analyst K. Kluska anticipates that the company will post earnings of ($0.08) per share for the year. Cantor Fitzgerald has […]
